December 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreOctober 01, 2025
The medical device CMO and CDMO market size is is set to grow significantly, driven by evolving consumer prefe...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 01, 2025
The medical thromboelastography machine market is rapidly growing due to TEG’s role in major surgeries and emergency bleeding control. Recent FDA approvals of Haemonetics' TEG 6s and Werfen’s ROTEM sigma have advanced this technology for use in cardiovascular, liver, and trauma care, improving patient outcomes....
November 01, 2025
Synthetic nerve conduits are essential in nerve tissue engineering, helping bridge nerve gaps for regeneration. The market is growing, driven by synthetic polymers that mimic nerve tissue properties. North America leads due to high nerve injury rates and advanced healthcare, while Europe, especially Germany, sees strong growth through research and ...
November 01, 2025
The absorbable nerve conduits market is set to rise from an estimated $4.97 bn in 2025 to $6.19 bn by 2030. The bioabsorbable nerve conduit market, projected to reach $4.97 billion by 2025, leverages materials like PLA and PCL for effective nerve repair. North America leads in demand due to increasing neurological disorders, while Asia-Pacific show...
November 01, 2025
The compounded topical drug market is growing due to increasing skin disorders affecting 1.8 billion people, personalized medicine demands, and drug shortages. Compounding allows for tailored medications without allergens. Key trends include Medisca's acquisition of liposomal bases in May 2022 and the FDA's addition of new APIs for compounding. Cal...
November 01, 2025
Market insights predict, the resorbable nerve conduits industry is expected to grow from USD 2.49 billion in 2024 to USD 5.28 billion by 2034, driven by a CAGR of 7.8%. The rising demand to treat nerve injuries by reducing the risk of inflammation and regenerating nerve with the presence of foreign body is increasing the adoption of resorbable nerv...
November 01, 2025
Photomedicine, which uses photons for medical diagnostics and treatments, spans fields like surgery, cardiology, cancer care, and dermatology. Recent advancements reveal new insights into photodamage. Companies like AVAVA and Cynosure are driving growth with substantial investments in targeted laser technologies....
November 01, 2025
Androgenetic alopecia, a genetic condition causing gradual hair loss, affects up to 50% of men and women, with Caucasians showing the highest prevalence. In 2024, Pelage Pharmaceuticals raised $16.75M for hair loss therapies, while a company raised $4M to treat this genetic condition....
November 01, 2025
RNA-based therapies are rapidly growing, offering new treatment possibilities for diseases like cancer, neurological disorders, and infections. Recent advancements in mRNA, ASO, and siRNA technologies have led to new approvals, with more in development. These therapies offer targeted, risk-free solutions with broad potential....
November 01, 2025
Induced pluripotent stem cells (iPSCs) are versatile cells derived from adult skin or blood, capable of transforming into any cell type. Widely used in regenerative medicine, disease modeling, and drug discovery, iPSCs are driving innovation, fueled by rising R&D and investment in stem cell therapies....
November 01, 2025
G-protein-coupled receptors (GPCRs) are critical targets in treating various diseases, including cardiovascular conditions. Recent investments, such as Superluminal's $120 million Series A funding and St. Jude's research collaboration, highlight the growing focus on developing innovative GPCR-targeting therapies, including AI-driven drug discovery....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com